Other

Use of Recombinant Activated Factor VIIa in a Six-Month-Old Child Due to Massive Hemorrhage During Elective Surgery for Choroid Plexus Carcinoma: Case Report

Alenka Spindler Vesel orcid.org/0000-0002-6490-8451 ; Clinical Department of Anesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia
Vesna Novak-Jankovič ; Clinical Department of Anesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia
Branka Maldini ; Department of Anesthesiology and Intensive Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Neva Požar Lukanović ; Clinical Department of Anesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia
Kata Denić ; Clinical Department of Anesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia
Jasmina Markovič-Božič ; Clinical Department of Anesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia
Maja Šoštarič ; Clinical Department of Anesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia

Abstract

We present the use of recombinant activated factor VIIa (rFVIIa) in a 6-month-old infant that suffered massive bleeding and subsequent coagulation disturbances during elective surgery for choroid plexus carcinoma in the lateral ventricle. The administration of rFVIIa resulted in good hemostasis. No intra- or postoperative thromboembolic complications were observed.

Keywords

Choroid plexus carcinoma – surgery; Surgical procedures, operative – complications; Hemorrhage; Supratentorial neoplasms – surgery; Recombinant FVIIa; Child

Hrčak ID:

148983

URI

https://hrcak.srce.hr/148983

Publication date:

1.11.2015.

Article data in other languages: croatian

Visits: 1.735 *